Literature DB >> 9091908

Serum-free keloid fibroblast cell culture: an in vitro model for the study of aberrant wound healing.

R J Koch1, R L Goode, G T Simpson.   

Abstract

The purpose of this study was to develop an in vitro serum-free keloid fibroblast model. Keloid formation remains a problem for every surgeon. Prior evaluations of fibroblast characteristics in vitro, especially those of growth factor measurement, have been confounded by the presence of serum-containing tissue culture media. The serum itself contains growth factors, yet has been a "necessary evil" to sustain cell growth. The design of this study is laboratory-based and uses keloid fibroblasts obtained from five patients undergoing facial (ear lobule) keloid removal in a university-affiliated clinic. Keloid fibroblasts were established in primary cell culture and then propagated in a serum-free environment. The main outcome measures included sustained keloid fibroblast growth and viability, which was comparable to serum-based models. The keloid fibroblast cell cultures exhibited logarithmic growth, sustained a high cellular viability, maintained a monolayer, and displayed contact inhibition. Demonstrating model consistency, there was no statistically significant difference between the mean cell counts of the five keloid fibroblast cell lines at each experimental time point. The in vitro growth of keloid fibroblasts in a serum-free model has not been done previous to this study. The results of this study indicate that the proliferative characteristics described are comparable to those of serum-based models. The described model will facilitate the evaluation of potential wound healing modulators, and cellular effects and collagen modifications of laser resurfacing techniques, and may serve as a harvest source for contaminant-free fibroblast autoimplants. Perhaps its greatest utility will be in the evaluation of endogenous and exogenous growth factors.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9091908     DOI: 10.1097/00006534-199704000-00027

Source DB:  PubMed          Journal:  Plast Reconstr Surg        ISSN: 0032-1052            Impact factor:   4.730


  4 in total

1.  Keloid-derived fibroblasts are refractory to Fas-mediated apoptosis and neutralization of autocrine transforming growth factor-beta1 can abrogate this resistance.

Authors:  T Chodon; T Sugihara; H H Igawa; E Funayama; H Furukawa
Journal:  Am J Pathol       Date:  2000-11       Impact factor: 4.307

2.  Use of synthetic serum-free medium for culture of human dermal fibroblasts to establish an experimental system similar to living dermis.

Authors:  Hirotaka Ejiri; Tadashi Nomura; Masumi Hasegawa; Chiaki Tatsumi; Midori Imai; Shunsuke Sakakibara; Hiroto Terashi
Journal:  Cytotechnology       Date:  2014-03-01       Impact factor: 2.058

3.  Models of abnormal scarring.

Authors:  Bommie F Seo; Jun Yong Lee; Sung-No Jung
Journal:  Biomed Res Int       Date:  2013-09-03       Impact factor: 3.411

4.  Sorafenib exerts an anti-keloid activity by antagonizing TGF-β/Smad and MAPK/ERK signaling pathways.

Authors:  Wenbo Wang; Miao Qu; Lan Xu; Xiaoli Wu; Zhen Gao; Tingyu Gu; Wenjie Zhang; Xiaoyan Ding; Wei Liu; Yue-Lei Chen
Journal:  J Mol Med (Berl)       Date:  2016-06-24       Impact factor: 4.599

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.